Facebook’s semi-independent oversight board says it will review the company’s “XCheck,” or cross check, system following an investigation by The Wall Street Journal into the use of this internal system that has exempted high-profile users from some or all of its rules.

The board said Tuesday that it expects to have a briefing with Facebook on the matter and “will be reporting what we hear from this” as part of a report it will publish in October. It may also make other recommendations, although Facebook is not bound to follow these.

The Journal's report found that many VIP users abuse the system, “posting material including harassment and incitement to violence that would typically lead to sanctions." For certain elite users, Facebook's rules don't seem to apply. Facebook Inc. had told The Journal that the system “was designed for an important reason: to create an additional step so we can accurately enforce policies on content that could require more understanding.” The company added that criticism of it was “fair" and that it was working to fix it.

A representative for Facebook declined to comment further on Tuesday.

The Journal's report, the board said, has drawn “renewed attention to the seemingly inconsistent way that the company makes decisions, and why greater transparency and independent oversight of Facebook matter so much for users."

Share:
More In Business
Poll: More Americans think companies benefit from legal immigration
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Tylenol maker rebounds a day after unfounded claims about its safety
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
Load More